Roger Waltzman

Roger Waltzman

Company: Molecular Templates

Job title: Chief Medical Officer

Seminars:

Novel Immunotoxin MT-5111 in Avoiding Competition With & Overcoming the Primary Mechanisms of Tumor Resistance to Current HER2-Targeted Therapies 1:00 pm

• Exploring the drug discovery process: target identification and validation, antitumor effect, pathway understanding, biomarkers • Discussing potential indications • Discussing the biomarker and patient status • Latest data and future directionsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.